Holista Colltech Sees Strong Recovery and Sales Growth

Holista Colltech Limited (AU:HCT) has released an update.

Holista Colltech Limited reports a positive turnaround with an 18% increase in sales to $1.7M in the first quarter of FY24, driven by a surge in Dietary Supplements revenue. Operating costs have simultaneously decreased by 6%, reflecting effective cost management and easing inflation. The company anticipates further recovery in its Food Ingredients and Ovine Collagen divisions, bolstered by new sales agreements and product launches.

For further insights into AU:HCT stock, check out TipRanks’ Stock Analysis page.